4Cable TV International, Inc.
(OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ
Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel
for Name Change with FINRA
MIAMI, FL -- December 6, 2024 -- InvestorsHub
NewsWire -- 4Cable TV International, Inc. (OTC.PK:
CATV), a leading innovator in emerging industries, is pleased
to announce the signing of a Letter of Intent (LOI) to acquire
MariJ Pharmaceuticals, Inc. from Branded Legacy, Inc. (OTC.PK:
BLEG). This transformative LOI is expected to lead to an
acquisition agreement that will bolster CATV's position in the
rapidly growing CBD and wellness sector through MariJ's robust
portfolio of licenses, certifications, and operational assets.
MariJ Pharmaceuticals, based in Melbourne, Florida, specializes in
certified organic CBD extraction and production, with patented
processes, mobile extraction facilities, and a portfolio of
award-winning products. The LOI outlines the intent to acquire
MariJ's compounding pharmacy license, state-of-the-art
supercritical CO2 extraction equipment, certified organic refined
CBD inventory, and a range of advanced tools and technologies.
MariJ's assets also include a fleet of licensed and permitted
vehicles, tailored for on-site extraction and refinement
operations, which enhance geographic reach and service
capabilities.
The
LOI includes provisions for the acquisition of MariJ's intellectual
property, operational databases, customer lists, trademarks, and
organic certifications, as well as a patent for extraction and
processing technology. CATV aims to integrate MariJ's proven
formulations and products into its expanding wellness-focused
portfolio following the completion of the acquisition
agreement.
Strengthening Corporate Structure with New Legal
Counsel
In
addition to this strategic LOI, CATV has retained a seasoned SEC
attorney to oversee and expedite its corporate name change filing
with FINRA to "Category V Biotech, Inc." This move is part of the
company's broader strategy to align its branding with its evolving
business operations and growth trajectory.
David Oswald, CEO of MariJ Pharmaceuticals,
shared his optimism:
"As I step away from MariJ Pharmaceuticals to focus on growing
Sycamore Biopharma, which requires the full attention of me and my
team, I am confident that Michael
Feldenkrais and his team will do wonderful things with MariJ. This
agreement marks an exciting new chapter for MariJ, and I know it
will thrive under their innovative leadership."
Michael Feldenkrais, CEO of 4Cable TV
International, Inc., commented:
This LOI represents a major milestone for CATV as we continue to
diversify and strengthen our offerings in high-growth industries.
MariJ's assets, expertise, and proven success in the CBD space will
be instrumental in our next phase of growth. We are eager to
finalize the acquisition agreement."
The LOI and subsequent acquisition of MariJ Pharmaceuticals are key
steps in CATV's strategic evolution, positioning the company to
capitalize on expanding opportunities in the
wellness and CBD sectors. The retained legal counsel will ensure a
seamless transition as the company undergoes its name change,
reinforcing CATV's commitment to its shareholders and long-term
vision.
About MariJ Pharmaceuticals, Inc.:
MariJ Pharmaceuticals, Inc., based in
Melbourne, Florida, specializes in certified organic mobile
extraction and production of CBD from industrial hemp. Known for
its innovative technology and patented extraction processes, MariJ
offers HIPAA- compliant solutions to the pharmaceutical and
bio-product industries, serving wholesale and retail markets across
the United States.
About 4Cable TV International, Inc.:
4Cable TV International, Inc. (OTC.PK: CATV), soon to be known as
Category V Biotech, Inc., is a dynamic company focused on
leveraging opportunities in emerging markets. Through strategic
acquisitions and innovation, CATV is committed to delivering
high-quality products and services that enhance value for its
shareholders. With its focus on growth, the company continues to
explore new opportunities to expand its footprint in promising
industries.
Future Endeavors: Category V
Biotech, Inc is poised to embark on a new
era of growth, innovation, and value
creation. The company will continue to keep its shareholders
informed about key developments, milestones, and the progress of
its initiatives.
About Category V Biotech, Inc:
(Currently known as 4Cable TV International, Inc. until
change of name is completed) Category V Biotech, Inc is a
forward-thinking biotechnology company committed to leveraging
science and innovation to create Category V-type products with a
national impact. The company is dedicated to pushing the boundaries
of biotechnology and contributing to positive advancements on a
grand scale.
Safe Harbor Statement:
The
information provided in this release includes forward-looking
statements as defined by the Private Securities Litigation Reform
Act of 1995. These statements are based on current expectations and
projections of management and are subject to risks and
uncertainties that could cause actual outcomes to differ
materially. Forward-looking statements are not guarantees
of future performance. For more
details, refer to the Company's filings with the Securities and
Exchange Commission.
For investor inquiries and additional information, contact: Michael
Feldenkrais, CEO of Category V Biotech, Inc. Website: catvbt.com
Email: info@catvbt.com